Advertisement
Correspondence| Volume 70, ISSUE 5, e27-e28, September 01, 2011

Reply to: Epstein-Barr Virus Transformed DNA as a Source of False Positive Findings in Methylation Studies of Psychiatric Conditions

      Åberg and van den Oord (
      • Åberg K.
      • van den Oord E.J.C.G.
      Epstein–Barr virus transformed DNA as a source of false positive findings in methylation studies of psychiatric conditions.
      ) raised several important issues that keep the field of human methylation research divided and, indeed, deserve to be discussed explicitly. First, the authors suggest that two factors might explain similarity in methylation between central nervous system cells and cells sampled in the periphery: changes in the germ line or changes in early embryogenesis. Second, they suggest that there are two alternatives for measuring methylation with peripheral indexes: lymphoblast cell lines or WB. Finally, they conclude that, given the choice between WB and high-pass lymphoblast cell lines, WB would be superior. We disagree with both the assumptions and the conclusion, and we briefly address each of the points below.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Åberg K.
        • van den Oord E.J.C.G.
        Epstein–Barr virus transformed DNA as a source of false positive findings in methylation studies of psychiatric conditions.
        Biol Psychiatry. 2011; 70: e25-e26
        • Van IJzendoorn M.H.
        • Caspers K.
        • Bakermans-Kranenburg M.J.
        • Beach S.R.
        • Philibert R.
        Methylation matters: Interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma.
        Biol Psychiatry. 2010; 68: 405-407
        • Morello F.
        • de Bruin T.W.
        • Rotter J.I.
        • Pratt R.E.
        • van der Kallen C.J.
        • Hladik G.A.
        • et al.
        Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
        Arterioscler Thromb Vasc Biol. 2004; 24: 2149-2154
        • Grafodatskaya D.
        • Choufani S.
        • Ferreira J.C.
        • Butcher D.T.
        • Lou Y.
        • Zhao C.
        • et al.
        EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines.
        Genomics. 2009; 95: 73-83
        • Plagnol V.
        • Uz E.
        • Wallace C.
        • Stevens H.
        • Clayton D.
        • Ozcelik T.
        • Todd J.A.
        Extreme clonality in lymphoblastoid cell lines with implications for allele specific expression analyses.
        PLoS ONE. 2008; 3: e2966
        • Ji H.
        • Ehrlich L.I.
        • Seita J.
        • Murakami P.
        • Doi A.
        • Lindau P.
        • et al.
        Comprehensive methylome map of lineage commitment from haematopoietic progenitors.
        Nature. 2010; 467: 338-342
        • Rollins B.
        • Martin M.V.
        • Morgan L.
        • Vawter M.P.
        Analysis of whole genome biomarker expression in blood and brain.
        Am J Med Genet B Neuropsychiatr Genet. 2010; 153B: 919-936

      Linked Article

      • Epstein–Barr Virus Transformed DNA as a Source of False Positive Findings in Methylation Studies of Psychiatric Conditions
        Biological PsychiatryVol. 70Issue 5
        • Preview
          Methylation patterns are tissue-specific (1). Methylation studies are therefore ideally performed in the tissue that is directly related to the disease of interest. However, for psychiatric conditions, it is not feasible to obtain brain tissue from (living) patients. In these instances, whole blood might serve as a proxy. There is indeed ample evidence suggesting that methylation signatures might not be limited to the affected tissue and are detectible in peripheral biofluids. One example involves the loss of imprinting of insulin-like growth factor-2, one of the best-studied epimutations that is associated with increased risk of colorectal cancer (2).
        • Full-Text
        • PDF